ARTL Stock Analysis: Buy, Sell, or Hold?

ARTL - Artelo Biosciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$10.54
7.35 (230.41%) ▲
5d: +32.25%
30d: +750.0%
90d: +567.09%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026

Get Alerted When ARTL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ARTL is 75.4% above fair value ($6.01). While momentum could continue, risk/reward favors waiting for a pullback.

In-depth Analysis How we analyze

Valuation Analysis: ARTL is currently trading at $10.54, which is considered extended relative to its 30-day fair value range of $0.71 to $6.01.

Technical Outlook: Technically, ARTL is in a uptrend. Immediate support is located at $2.96, while resistance sits at $14.96. The stock is showing strong short-term momentum, up 230.4% recently.

Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+70.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $0.71 - $6.01
Company Quality Score 50/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 52.6%

All Signals

  • BEARISH: Price significantly overextended (+75.4% above fair value)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: Strong upward momentum (+230.4%)
  • BULLISH: Trading 70.8% below Wall St target ($18.00)
  • WARNING: Recommendation downgraded due to 75.4% overvaluation

Fair Price Analysis

30-Day Fair Range $0.71 - $6.01
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $2.96
Resistance Level $14.96
Current Trend Uptrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) -3.21
Wall Street Target $18.00 (+70.8%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 8:25 AM ET
Data refreshes hourly during market hours. Next update: 9:25 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ARTL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$89 54 HOLD
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$58 53 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 53 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$119 60 BUY
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$547 42 HOLD

More Analysis for ARTL

ARTL Technical Chart ARTL Price Prediction ARTL Earnings Date Why is ARTL Moving Today? ARTL Investment Advisor ARTL Fair Price Analyzer ARTL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals